Skip to main content
. 2013 Jun 7;27(8):931–939. doi: 10.1038/eye.2013.114

Figure 2.

Figure 2

The graph shows the mean logMAR BCVA (a), the distribution of the mean BCVA changes from baseline (b), and the CRT (c) after treatment with IVR injections for eyes with PCV having recurrent or residual exudation from branching vascular networks after previous PDT. (a) A significant improvement in the mean BCVA is seen at months 12 and 24 compared with baseline (P<0.0001, P=0.0012, respectively, by the paired t-test). Months 12 and 24 are equivalent to 12 and 24 months after treatment. (b) No eyes had decreased BCVA of three lines or more after treatment over 24 months. Months 12 and 24 are equivalent to 12 and 24 months after treatment. (c) A significant decrease in the CRT is seen at months 12 and 24 compared with baseline (P<0.0038, P<0.001, respectively, by the paired t-test).